Canada - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVaccine Price in Canada - 2022
Contents:
- Vaccine Price in Canada (CIF) - 2022
- Vaccine Price in Canada (FOB) - 2022
- Vaccine Imports in Canada
- Vaccine Exports in Canada
Vaccine Price in Canada (CIF) - 2022
In 2022, the average vaccine import price amounted to $732,252 per ton, falling by -1.7% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +4.1%. The most prominent rate of growth was recorded in 2021 when the average import price increased by 12%. As a result, import price reached the peak level of $744,856 per ton, and then contracted in the following year.
Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from France ($732,327 per ton) and Belgium ($732,326 per ton), while the price for Switzerland ($732,307 per ton) and Ireland ($732,309 per ton) were amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Ireland (+14.0%), while the prices for the other major suppliers experienced more modest paces of growth.
Vaccine Price in Canada (FOB) - 2022
The average vaccine export price stood at $616,975 per ton in 2022, almost unchanged from the previous year. Over the period under review, the export price, however, saw a tangible expansion. The growth pace was the most rapid in 2015 an increase of 531%. As a result, the export price reached the peak level of $2,597 per kg. From 2016 to 2022, the average export prices remained at a somewhat lower figure.
Average prices varied noticeably for the major external markets. In 2022, amid the top suppliers, the countries with the highest prices were France ($617,750 per ton) and Mexico ($617,748 per ton), while the average price for exports to Belgium ($617,738 per ton) and the United States ($617,743 per ton) were amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to France (+4.1%), while the prices for the other major destinations experienced more modest paces of growth.
Vaccine Imports in Canada
Vaccine imports into Canada dropped markedly to 2.3K tons in 2022, reducing by -40.5% on the previous year's figure. In general, imports, however, showed significant growth. The most prominent rate of growth was recorded in 2021 when imports increased by 427% against the previous year. As a result, imports reached the peak of 3.8K tons, and then reduced dramatically in the following year.
In value terms, vaccine imports reduced rapidly to $1.7B in 2022. Overall, imports, however, saw a significant expansion. The pace of growth appeared the most rapid in 2021 with an increase of 490%. As a result, imports attained the peak of $2.8B, and then declined rapidly in the following year.
Import of Vaccine in Canada (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
United States | 156 | 176 | 2,005 | 1,263 | 100.8% |
Belgium | 147 | 95.6 | 341 | 215 | 13.5% |
Switzerland | 89.7 | 40.5 | 93.0 | 58.6 | -13.2% |
Italy | 4.1 | 44.8 | 58.2 | 36.7 | 107.6% |
Ireland | 65.9 | 55.6 | 40.3 | 32.5 | -21.0% |
France | 16.5 | 34.9 | 28.7 | 18.1 | 3.1% |
Spain | N/A | 6.0 | 213 | N/A | 3450.0% |
Others | 29.6 | 25.7 | 48.2 | 29.5 | -0.1% |
Total | 509 | 479 | 2,827 | 1,653 | 48.1% |
Top Suppliers of Vaccine to Canada in 2022:
- United States (1725.1 tons)
- Belgium (293.1 tons)
- Switzerland (80.0 tons)
- Italy (50.1 tons)
- Ireland (44.4 tons)
- France (24.7 tons)
Vaccine Exports in Canada
In 2022, the amount of vaccines for human medicine exported from Canada totaled 664 tons, standing approx. at the previous year. The total export volume increased at an average annual rate of +3.2% over the period from 2019 to 2022; the trend pattern remained relatively stable, with only minor fluctuations throughout the analyzed period. The growth pace was the most rapid in 2020 when exports increased by 11%. As a result, the exports attained the peak of 669 tons. From 2021 to 2022, the growth of the exports remained at a somewhat lower figure.
In value terms, vaccine exports amounted to $410M in 2022. In general, exports, however, continue to indicate a pronounced decrease.
Export of Vaccine in Canada (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
United States | 342 | 346 | 306 | 318 | -2.4% |
Belgium | 20.7 | 22.9 | 33.4 | 32.6 | 16.3% |
France | 37.6 | 23.9 | 22.6 | 26.9 | -10.6% |
Mexico | 9.4 | 1.3 | 7.0 | 6.8 | -10.2% |
Uganda | N/A | N/A | 1.9 | N/A | 0% |
Others | 38.4 | 15.7 | 38.6 | 25.8 | -12.4% |
Total | 448 | 410 | 410 | 410 | -2.9% |
Top Export Markets for Vaccine from Canada in 2022:
- United States (514.4 tons)
- Belgium (52.7 tons)
- France (43.5 tons)
- Mexico (11.0 tons)
This report provides an in-depth analysis of the vaccine market in Canada. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Canada
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Canada
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
This report provides an in-depth analysis of the vaccine market in Canada.
This report provides an in-depth analysis of the antisera market in Canada.
This report provides an in-depth analysis of the biological product market in Canada.
This report provides an in-depth analysis of the market for human and animal blood in Canada.
This report provides an in-depth analysis of the veterinary medicine vaccines market in Canada.
This report provides an in-depth analysis of the global vaccine market.
This report provides an in-depth analysis of the global antisera market.
This report provides an in-depth analysis of the global biological product market.
This report provides an in-depth analysis of the global market for human and animal blood.
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
Imports of Vaccines peaked at 3.3K tons in 2022, only to contract in the following year. The value of vaccine imports also decreased to $3.1B in 2023.
From 2022 to 2023, the growth of imports in the Human And Animal Blood sector failed to regain momentum. In value terms, imports sharply declined to $263M in 2023.
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...